Huayu Pharmaceuticals (688553.SH): Multiple products obtain overseas listing permits.

Beijing Securities News App News, Huiyu Pharmaceutical (688553.SH) announced that its subsidiary, Seacross Pharmaceuticals Ltd., has recently received approval from the Pakistan Drug Regulatory Authority, the UK Drug and Health Products Regulatory Authority, and the North Macedonian Drug and Medical Device Management Authority for the market approval of the company's products Pule Shafu injection, injection of Setipai, injection of Azacytidine, concentrated solution of Zoledronic acid, and Zoledronic acid injection.